| Product Code: ETC7742921 | Publication Date: Sep 2024 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Shubham Padhi | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Japan Monogenic Disease Testing Market Overview |
3.1 Japan Country Macro Economic Indicators |
3.2 Japan Monogenic Disease Testing Market Revenues & Volume, 2021 & 2031F |
3.3 Japan Monogenic Disease Testing Market - Industry Life Cycle |
3.4 Japan Monogenic Disease Testing Market - Porter's Five Forces |
3.5 Japan Monogenic Disease Testing Market Revenues & Volume Share, By Test Type, 2021 & 2031F |
3.6 Japan Monogenic Disease Testing Market Revenues & Volume Share, By Disease Type, 2021 & 2031F |
3.7 Japan Monogenic Disease Testing Market Revenues & Volume Share, By End use, 2021 & 2031F |
4 Japan Monogenic Disease Testing Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of monogenic diseases in Japan |
4.2.2 Technological advancements in genetic testing leading to more accurate and efficient testing methods |
4.2.3 Growing awareness and adoption of personalized medicine in Japan |
4.3 Market Restraints |
4.3.1 High costs associated with genetic testing and limited insurance coverage for monogenic disease testing |
4.3.2 Limited availability of specialized healthcare professionals for genetic counseling and interpretation of test results |
5 Japan Monogenic Disease Testing Market Trends |
6 Japan Monogenic Disease Testing Market, By Types |
6.1 Japan Monogenic Disease Testing Market, By Test Type |
6.1.1 Overview and Analysis |
6.1.2 Japan Monogenic Disease Testing Market Revenues & Volume, By Test Type, 2021- 2031F |
6.1.3 Japan Monogenic Disease Testing Market Revenues & Volume, By Carrier Testing, 2021- 2031F |
6.1.4 Japan Monogenic Disease Testing Market Revenues & Volume, By Diagnostic Testing, 2021- 2031F |
6.1.5 Japan Monogenic Disease Testing Market Revenues & Volume, By New-Born Screening, 2021- 2031F |
6.1.6 Japan Monogenic Disease Testing Market Revenues & Volume, By Predictive and Pre-Symptomatic Testing, 2021- 2031F |
6.1.7 Japan Monogenic Disease Testing Market Revenues & Volume, By Prenatal Testing, 2021- 2031F |
6.2 Japan Monogenic Disease Testing Market, By Disease Type |
6.2.1 Overview and Analysis |
6.2.2 Japan Monogenic Disease Testing Market Revenues & Volume, By Cystic fibrosis, 2021- 2031F |
6.2.3 Japan Monogenic Disease Testing Market Revenues & Volume, By Sickle Cell Anemia, 2021- 2031F |
6.2.4 Japan Monogenic Disease Testing Market Revenues & Volume, By Severe Combined Immunodeficiency (SCID), 2021- 2031F |
6.2.5 Japan Monogenic Disease Testing Market Revenues & Volume, By Tay-Sachs Disorder, 2021- 2031F |
6.2.6 Japan Monogenic Disease Testing Market Revenues & Volume, By Polycystic Kidney Disorder, 2021- 2031F |
6.2.7 Japan Monogenic Disease Testing Market Revenues & Volume, By Others, 2021- 2031F |
6.3 Japan Monogenic Disease Testing Market, By End use |
6.3.1 Overview and Analysis |
6.3.2 Japan Monogenic Disease Testing Market Revenues & Volume, By Hospitals, 2021- 2031F |
6.3.3 Japan Monogenic Disease Testing Market Revenues & Volume, By Ambulatory Surgical Centers, 2021- 2031F |
6.3.4 Japan Monogenic Disease Testing Market Revenues & Volume, By Specialized Clinics, 2021- 2031F |
7 Japan Monogenic Disease Testing Market Import-Export Trade Statistics |
7.1 Japan Monogenic Disease Testing Market Export to Major Countries |
7.2 Japan Monogenic Disease Testing Market Imports from Major Countries |
8 Japan Monogenic Disease Testing Market Key Performance Indicators |
8.1 Average turnaround time for test results |
8.2 Number of genetic testing facilities offering monogenic disease testing services in Japan |
8.3 Rate of adoption of genetic testing for monogenic diseases among healthcare providers |
9 Japan Monogenic Disease Testing Market - Opportunity Assessment |
9.1 Japan Monogenic Disease Testing Market Opportunity Assessment, By Test Type, 2021 & 2031F |
9.2 Japan Monogenic Disease Testing Market Opportunity Assessment, By Disease Type, 2021 & 2031F |
9.3 Japan Monogenic Disease Testing Market Opportunity Assessment, By End use, 2021 & 2031F |
10 Japan Monogenic Disease Testing Market - Competitive Landscape |
10.1 Japan Monogenic Disease Testing Market Revenue Share, By Companies, 2024 |
10.2 Japan Monogenic Disease Testing Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here